Literature DB >> 29762751

Clinically Meaningful Gaps Between Clinical Trials and Patient Treatment.

Robert W Buchanan, William T Carpenter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29762751      PMCID： PMC6007627          DOI： 10.1093/schbul/sby060

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN： 0586-7614            Impact factor:   9.306


× No keyword cloud information.
  5 in total

1.  A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.

Authors:  Robert W Buchanan; Miriam Davis; Donald Goff; Michael F Green; Richard S E Keefe; Andrew C Leon; Keith H Nuechterlein; Thomas Laughren; Robert Levin; Ellen Stover; Wayne Fenton; Steve R Marder
Journal:  Schizophr Bull       Date:  2005-02-16       Impact factor: 9.306

2.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

3.  Does switching to a new antipsychotic improve outcomes? Data from the CATIE Trial.

Authors:  Robert A Rosenheck; Sonia Davis; Nancy Covell; Susan Essock; Marvin Swartz; Scott Stroup; Joseph McEvoy; Jeffrey Lieberman
Journal:  Schizophr Res       Date:  2008-11-06       Impact factor: 4.939

Review 4.  Assessing the efficacy of treatments for the deficit syndrome of schizophrenia.

Authors:  B Kirkpatrick; A Kopelowicz; R W Buchanan; W T Carpenter
Journal:  Neuropsychopharmacology       Date:  2000-03       Impact factor: 7.853

Review 5.  Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology.

Authors:  Oliver D Howes; Rob McCutcheon; Ofer Agid; Andrea de Bartolomeis; Nico J M van Beveren; Michael L Birnbaum; Michael A P Bloomfield; Rodrigo A Bressan; Robert W Buchanan; William T Carpenter; David J Castle; Leslie Citrome; Zafiris J Daskalakis; Michael Davidson; Richard J Drake; Serdar Dursun; Bjørn H Ebdrup; Helio Elkis; Peter Falkai; W Wolfgang Fleischacker; Ary Gadelha; Fiona Gaughran; Birte Y Glenthøj; Ariel Graff-Guerrero; Jaime E C Hallak; William G Honer; James Kennedy; Bruce J Kinon; Stephen M Lawrie; Jimmy Lee; F Markus Leweke; James H MacCabe; Carolyn B McNabb; Herbert Meltzer; Hans-Jürgen Möller; Shinchiro Nakajima; Christos Pantelis; Tiago Reis Marques; Gary Remington; Susan L Rossell; Bruce R Russell; Cynthia O Siu; Takefumi Suzuki; Iris E Sommer; David Taylor; Neil Thomas; Alp Üçok; Daniel Umbricht; James T R Walters; John Kane; Christoph U Correll
Journal:  Am J Psychiatry       Date:  2016-12-06       Impact factor: 18.112
  5 in total
  1 in total

1.  Antipsychotic Dose in Acute Schizophrenia: A Meta-analysis.

Authors:  Hiroyoshi Takeuchi; Nicole E MacKenzie; Dominic Samaroo; Ofer Agid; Gary Remington; Stefan Leucht
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.